IT1253431B - Preparati farmaceutici per uso topico destinati al trattamento della psoriasi e della dermatite atopica - Google Patents

Preparati farmaceutici per uso topico destinati al trattamento della psoriasi e della dermatite atopica

Info

Publication number
IT1253431B
IT1253431B ITBG910042A ITBG910042A IT1253431B IT 1253431 B IT1253431 B IT 1253431B IT BG910042 A ITBG910042 A IT BG910042A IT BG910042 A ITBG910042 A IT BG910042A IT 1253431 B IT1253431 B IT 1253431B
Authority
IT
Italy
Prior art keywords
psoriasis
treatment
atopic dermatitis
pharmaceutical preparations
topical use
Prior art date
Application number
ITBG910042A
Other languages
English (en)
Original Assignee
Valetudo S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valetudo S R L filed Critical Valetudo S R L
Priority to ITBG910042A priority Critical patent/IT1253431B/it
Publication of ITBG910042A0 publication Critical patent/ITBG910042A0/it
Priority to EP92119887A priority patent/EP0552439A1/en
Priority to KR1019920022776A priority patent/KR930012013A/ko
Priority to JP4349770A priority patent/JPH05286864A/ja
Publication of ITBG910042A1 publication Critical patent/ITBG910042A1/it
Application granted granted Critical
Publication of IT1253431B publication Critical patent/IT1253431B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Abstract

Il trovato si riferisce a preparati farmaceutici per uso topico destinati al trattamento della psoriasi e della dermatite atopica. Detti preparati sono caratterizzati dal fatto di contenere, come sostanze attive, silimorina in quantità compresa tra 0.3 e 3%p e/o teofillina e/o relativi derivati idrosolubili in quantità comprese tra 0.5 e 10%p e dal fatto di contenere, come sostanze coadiuvanti, troxerutina in quantità comprese tra 0.2e 2%p, acido beta-glicirretico in quantità comprese tra 0.4 e 2%p ed estratto secco di Ruscus Aculcatus in quantità comprese tra 0.05 e 5%p.
ITBG910042A 1991-12-02 1991-12-02 Preparati farmaceutici per uso topico destinati al trattamento della psoriasi e della dermatite atopica IT1253431B (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
ITBG910042A IT1253431B (it) 1991-12-02 1991-12-02 Preparati farmaceutici per uso topico destinati al trattamento della psoriasi e della dermatite atopica
EP92119887A EP0552439A1 (en) 1991-12-02 1992-11-23 Pharmaceutical preparations for topical use in the treatment of psoriasis and atopical dermatitis
KR1019920022776A KR930012013A (ko) 1991-12-02 1992-11-30 건선과 과민성 피부염 치료에 국소적으로 사용되는 제약학적 성분물
JP4349770A JPH05286864A (ja) 1991-12-02 1992-12-02 乾癬及びアトピー性皮膚炎治療用の局所適用製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBG910042A IT1253431B (it) 1991-12-02 1991-12-02 Preparati farmaceutici per uso topico destinati al trattamento della psoriasi e della dermatite atopica

Publications (3)

Publication Number Publication Date
ITBG910042A0 ITBG910042A0 (it) 1991-12-02
ITBG910042A1 ITBG910042A1 (it) 1993-06-02
IT1253431B true IT1253431B (it) 1995-08-08

Family

ID=11336083

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBG910042A IT1253431B (it) 1991-12-02 1991-12-02 Preparati farmaceutici per uso topico destinati al trattamento della psoriasi e della dermatite atopica

Country Status (4)

Country Link
EP (1) EP0552439A1 (it)
JP (1) JPH05286864A (it)
KR (1) KR930012013A (it)
IT (1) IT1253431B (it)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2065292B1 (es) * 1993-07-30 1995-09-16 Inkeysa Sa Composiciones terapeuticas de uso topico para el tratamiento de la psoriaris.
US6379714B1 (en) 1995-04-14 2002-04-30 Pharmaprint, Inc. Pharmaceutical grade botanical drugs
ES2137125B1 (es) * 1997-11-18 2000-08-16 Vinyals S A Lab Dr La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
WO1999063982A1 (en) * 1998-06-11 1999-12-16 University Of Medicine & Dentistry Of New Jersey Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
US7151082B2 (en) 1999-02-11 2006-12-19 The Feinstein Institute For Medical Research Antagonists of HMG1 for treating inflammatory conditions
US6303321B1 (en) 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
ITMI20010429A1 (it) 2001-03-02 2002-09-02 Indena Spa Composizioni farmaceutiche e cosmetiche per la protezione della pelledai danni indotti dalle radiazioni solari
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
DE10225772A1 (de) * 2002-06-10 2003-12-24 Beiersdorf Ag Kosmetische oder dermatologische Formulierungen zur Pflege der Haut nach einem Sonnenbad oder einer Rasur
US7696169B2 (en) 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
CN1878793A (zh) 2003-09-11 2006-12-13 鉴定医疗有限公司 拮抗hmgb1的单克隆抗体
JP4033877B2 (ja) 2005-09-29 2008-01-16 株式会社ファンケル I型コラーゲン産生促進用組成物
DE102005048780A1 (de) * 2005-10-10 2007-04-12 Beiersdorf Ag Wasserhaltige kosmetische Zubereitung mit gelösten Flavonolignanen
EP1902755A1 (en) * 2006-09-19 2008-03-26 Cognis IP Management GmbH Cosmetic compositions decreasing GM-CSF release induced by nickel salts
EP1902756A1 (en) * 2006-09-19 2008-03-26 Cognis IP Management GmbH Composition and method for treating skin by administering silybin and piperine/terahydropiperine
WO2016149685A1 (en) 2015-03-19 2016-09-22 Cydex Pharmaceuticals, Inc. Compositions containing silymarin and sulfoalkyl ether cyclodextrin and methods of using the same
CN104887630A (zh) * 2015-05-15 2015-09-09 大连理工大学 一种脂质体包覆脱氢水飞蓟宾磷脂复合物及其制备方法
FR3053253B1 (fr) * 2016-07-01 2020-01-17 Pierre Fabre Dermo-Cosmetique Nouvel extrait d'akenes de silybum marianum et ses utilisations en dermatologie et dermo-cosmetique
JP7165487B2 (ja) * 2016-12-27 2022-11-04 花王株式会社 抗菌ペプチド発現促進剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2235678A1 (en) * 1973-07-02 1975-01-31 Merck & Co Inc Topical antipsoriasis agents - contg. prostaglandin E1 or E2
US3957994A (en) * 1974-12-19 1976-05-18 Nelson Research & Development Company Topical anti-inflammatory composition and method of use
JPS60188315A (ja) * 1984-03-07 1985-09-25 Yamanouchi Pharmaceut Co Ltd グリチルレチン酸配合鎮痒プラスター
FR2594691B1 (fr) * 1986-02-24 1990-08-03 Bonne Claude Nouvelles preparations cosmetiques contenant un extrait des fruits de silybum marianum
EP0278809B1 (fr) * 1987-01-19 1992-03-25 Parfums Rochas Nouvelles compositions cosmétiques ou dermatologiques renfermant un extrait des fruits de Silybum Marianum riche en Silymarine associé à des acides gras essentiels

Also Published As

Publication number Publication date
JPH05286864A (ja) 1993-11-02
ITBG910042A0 (it) 1991-12-02
ITBG910042A1 (it) 1993-06-02
KR930012013A (ko) 1993-07-20
EP0552439A1 (en) 1993-07-28

Similar Documents

Publication Publication Date Title
IT1253431B (it) Preparati farmaceutici per uso topico destinati al trattamento della psoriasi e della dermatite atopica
ZA89233B (en) Topical metronidazole formulations and therapeutic uses thereof
IT1287114B1 (it) Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
IT1201149B (it) Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
EE04239B1 (et) Hüdroksüülamiini derivaadid, mis on kasutatavad molekulaarse seostusvalgu moodustumise suurendamiseks, ja nende valmistamine
TR200003158T2 (tr) Jelleşebilen farmasötik bileşimler
MX9308199A (es) Inhibidores de enzima.
PT948527E (pt) Novos derivados de ciclosporina sua preparacao e composicoes farmaceuticas que os contem
TW234691B (it)
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
DK0785769T3 (da) Terapeutisk vitamin-calcium-kombination i form af en galenisk enhedsdosistablet, fremgangsmåde til fremstilling af denne sa
EP0824915A3 (de) Herstellung von Glycoglycerolipiden, deren Verwendung als Tenside sowie kosmetische oder dermatologische Zubereitungen, solche Glycoglycerolipide enthaltend
IT8123602A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
HUP9902287A1 (hu) Szintetikus poliszacharidok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
DE50012571D1 (de) Biotin enthaltende galenische formulierung
DK284386A (da) Farmaceutisk praeparat mod hudlidelser
ES2010161A4 (es) Utilizacion de una mezcla para el tratamiento de la alopecia
IT1256623B (it) Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
NO970178L (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
AU4142999A (en) Topical pharmaceutical compositions useful for the treatment of cutaneous or circulatory pathologies on inflammatory, immune, proliferative or degenerative basis
ZA91115B (en) Topical compositions
SE8403659L (sv) Synergistiska farmaceutiska kompositioner
IT1237509B (it) Complessi con le ciclodestrine indicati per il trattamento di tutte leforme anemiche da carenza di folati, loro preparazione e relative composizioni farmaceutiche

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961202